| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis
|
Kong, A.
|
|
|
18 |
10 |
p. 1595-1604
|
artikel
|
| 2 |
A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes
|
Findlay, B.
|
|
|
18 |
10 |
p. 1646-1651
|
artikel
|
| 3 |
Burden of cervical cancer in Europe: estimates for 2004
|
Arbyn, M.
|
|
|
18 |
10 |
p. 1708-1715
|
artikel
|
| 4 |
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer
|
Xenidis, N.
|
|
|
18 |
10 |
p. 1623-1631
|
artikel
|
| 5 |
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer
|
Kim, S.Y.
|
|
|
18 |
10 |
p. 1698-1703
|
artikel
|
| 6 |
Current role of allogeneic stem cell transplantation in breast cancer
|
Carella, A.M.
|
|
|
18 |
10 |
p. 1591-1593
|
artikel
|
| 7 |
FDG-PET in T-cell and NK-cell neoplasms
|
Kako, S.
|
|
|
18 |
10 |
p. 1685-1690
|
artikel
|
| 8 |
Incidence of childhood cancer of the head and neck in Germany
|
Gosepath, J.
|
|
|
18 |
10 |
p. 1716-1721
|
artikel
|
| 9 |
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study
|
Heinemann, V.
|
|
|
18 |
10 |
p. 1652-1659
|
artikel
|
| 10 |
Interplay of distinct growth factors during epithelial–mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies
|
Mimeault, M.
|
|
|
18 |
10 |
p. 1605-1619
|
artikel
|
| 11 |
in this issue
|
|
|
|
18 |
10 |
p. 1589
|
artikel
|
| 12 |
Neutrophilic dermatitis associated with bortezomib in a patient with multiple myeloma
|
Paiva, C.M.
|
|
|
18 |
10 |
p. 1744-1745
|
artikel
|
| 13 |
Overdose with 6400 mg of imatinib: is it safe?
|
Bhargav, R.
|
|
|
18 |
10 |
p. 1750-1751
|
artikel
|
| 14 |
Oxytocin: bringing magic into nipple aspiration
|
Suijkerbuijk, K.P.M.
|
|
|
18 |
10 |
p. 1743-1744
|
artikel
|
| 15 |
Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: A proposal for standardization of patient characteristic reporting and stratification
|
Sorbye, H.
|
|
|
18 |
10 |
p. 1666-1672
|
artikel
|
| 16 |
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma† † For the National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. This work was presented at the 2005 Meeting of the American Society of Hematology.
|
Macdonald, D.A.
|
|
|
18 |
10 |
p. 1680-1684
|
artikel
|
| 17 |
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered™ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
|
Goel, S.
|
|
|
18 |
10 |
p. 1704-1707
|
artikel
|
| 18 |
Profound graft-versus-tumor response in metastatic breast cancer with nonmyeloablative allografting
|
Carella, A.M.
|
|
|
18 |
10 |
p. 1751-1754
|
artikel
|
| 19 |
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer
|
Colleoni, M.
|
|
|
18 |
10 |
p. 1632-1640
|
artikel
|
| 20 |
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-α2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma
|
Middleton, M.
|
|
|
18 |
10 |
p. 1691-1697
|
artikel
|
| 21 |
Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy
|
van der Veldt, A.A.M.
|
|
|
18 |
10 |
p. 1747-1750
|
artikel
|
| 22 |
Sorafinib in kidney cancer
|
|
|
|
18 |
10 |
p. 1755
|
artikel
|
| 23 |
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial
|
Lorenzen, S.
|
|
|
18 |
10 |
p. 1673-1679
|
artikel
|
| 24 |
Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome
|
Kapiteijn, E.
|
|
|
18 |
10 |
p. 1745-1747
|
artikel
|
| 25 |
Table of Contents
|
|
|
|
18 |
10 |
p. i-ii
|
artikel
|
| 26 |
Therapeutic impact of FDG-PET in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer
|
|
|
|
18 |
10 |
p. 1756
|
artikel
|
| 27 |
Up-to-date monitoring of childhood cancer long-term survival in Europe: central nervous system tumours
|
Arndt, V.
|
|
|
18 |
10 |
p. 1734-1742
|
artikel
|
| 28 |
Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas
|
Arndt, V.
|
|
|
18 |
10 |
p. 1722-1733
|
artikel
|
| 29 |
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
|
Mandalà, M.
|
|
|
18 |
10 |
p. 1660-1665
|
artikel
|
| 30 |
What happened in Italy? A brief summary of studies conducted in Italy to evaluate the impact of the smoking ban
|
Gorini, G.
|
|
|
18 |
10 |
p. 1620-1622
|
artikel
|
| 31 |
Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?
|
Bresser, P.J.C.
|
|
|
18 |
10 |
p. 1641-1645
|
artikel
|
Tijdschrift beschrijving